Calliditas Therapeutics AB (CALT)
21.71
+0.21
(+0.98%)
USD |
NASDAQ |
May 22, 16:00
21.88
+0.17
(+0.78%)
After-Hours: 20:00
Calliditas Therapeutics Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | -31.04M |
| September 30, 2022 | -70.79M |
| June 30, 2022 | -64.74M |
| March 31, 2022 | -58.45M |
| December 31, 2021 | -53.93M |
| September 30, 2021 | -47.18M |
| June 30, 2021 | -56.67M |
| March 31, 2021 | -47.84M |
| December 31, 2020 | -33.77M |
| September 30, 2020 | -26.21M |
| June 30, 2020 | -4.885M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.080M |
| December 31, 2019 | -7.518M |
| September 30, 2019 | -7.856M |
| June 30, 2019 | -18.14M |
| March 31, 2019 | -15.98M |
| December 31, 2018 | -14.77M |
| September 30, 2018 | -12.47M |
| June 30, 2018 | -13.33M |
| March 31, 2018 | -10.74M |
| December 31, 2017 | -7.980M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-70.79M
Minimum
Sep 2022
-4.080M
Maximum
Mar 2020
-35.54M
Average
-33.77M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
| DBV Technologies SA | -93.50M |
| Cellectis SA | -24.75M |
| Adaptimmune Therapeutics PLC | -135.55M |
| Akari Therapeutics PLC | -22.19M |
| Biodexa Pharmaceuticals Plc | -8.515M |